Sign In
Buy SLP
$16.17
-0.600 (-3.58%)
At Close: Jun 03, 2026
Simulations Plus Supported Development of Every FDA-Approved Drug in 2024
07:50am, Monday, 13'th Jan 2025
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--SLP highlighted its impact on the pharmaceutical industry through supporting the development of 100% of the drugs approved by the U.S. FDA in 2024.
Simulations Plus' Q1 Earnings Lag Estimates, Revenues Surge Y/Y
08:31am, Wednesday, 08'th Jan 2025
SLP's fiscal first-quarter performance is driven by healthy revenue growth across its Software segment and contributions from the acquisition of Pro-ficiency.
Simulations Plus, Inc. (SLP) Q1 2025 Earnings Call Transcript
09:08pm, Tuesday, 07'th Jan 2025
Simulations Plus, Inc. (NASDAQ:SLP ) Q1 2025 Earnings Conference Call January 7, 2025 5:00 PM ET Company Participants Lisa Fortuna - IR, Financial Profiles Shawn O'Connor - CEO Will Frederick - CFO &
Simulations Plus (SLP) Lags Q1 Earnings Estimates
06:26pm, Tuesday, 07'th Jan 2025
Simulations Plus (SLP) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.10 per share a year ago.
Simulations Plus Reports First Quarter Fiscal 2025 Financial Results
04:06pm, Tuesday, 07'th Jan 2025
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and i
3 Software Stocks to Keep an Eye on Amid Industry Headwinds
02:00pm, Tuesday, 07'th Jan 2025
Amid volatile macroeconomic conditions, Computer Software industry participants like ADSK, BB and SLP are well-poised to capitalize on digital transformation and strong adoption of cloud computing sol
Simulations Plus Gears Up for Q1 Earnings: What's in Store?
09:36am, Monday, 06'th Jan 2025
SLP's fiscal first quarter performance is likely to have gained from strength in both Software and Services' segments.
Simulations Plus Announces First Quarter Fiscal Year 2025 Earnings and Conference Call Date
04:06pm, Tuesday, 17'th Dec 2024
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solut
Wall Street Analysts Predict a 56.99% Upside in Simulations Plus (SLP): Here's What You Should Know
10:55am, Tuesday, 26'th Nov 2024
The consensus price target hints at a 57% upside potential for Simulations Plus (SLP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings est
Simulations Plus (SLP) Stock Jumps 8.9%: Will It Continue to Soar?
08:16am, Friday, 22'nd Nov 2024
Simulations Plus (SLP) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more str
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, in partnership with the University of Connecticut, was awarded a new FDA grant to investigate additional LAI product technologies.
How Much Upside is Left in Simulations Plus (SLP)? Wall Street Analysts Think 77.52%
10:55am, Friday, 08'th Nov 2024
The consensus price target hints at a 77.5% upside potential for Simulations Plus (SLP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings e
Simulations Plus to Participate in the Stephens Annual Investment Conference
08:30am, Wednesday, 06'th Nov 2024
LANCASTER, Calif.--(BUSINESS WIRE)--Shawn O'Connor, CEO, will participate in a fireside chat at the Stephens Annual Investment Conference on Wednesday, November 20, 2024 at 12:00pm ET.
Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations
08:30am, Wednesday, 30'th Oct 2024
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, with industry and academic partners, was awarded a new FDA grant to validate new methods for more efficient drug development.
Simulations Plus' Q4 Earnings Top Estimates on Solid Revenue Growth
10:46am, Thursday, 24'th Oct 2024
SLP's fiscal fourth-quarter performance is driven by healthy revenue growth across its software and services business segments.
